U.S. Electrical Stock News

Septerna (SEPN) has begun dosing the first participants in its Phase 1 trial of SEP-479, an oral PTH1R agonist for hypoparathyroidism, marking a key milestone that now puts early safety data in focus. See our latest analysis for Septerna. The Phase 1 dosing update comes as Septerna’s share price sits at $24.13, with a 1-day share price return of 3.38% contrasting with a 90-day share price return of a 9.73% decline and a 1-year total shareholder return of 283.62%. This suggests earlier...

Clinical collaboration puts fresh focus on Incyte stock Incyte (INCY) is back on investor radars after Adagene announced a clinical collaboration, pairing muzastotug with Incyte’s bispecific antibody INCA33890 in microsatellite stable colorectal cancer. The planned Phase 1 study, expected to start in 2026, will be sponsored and conducted by Incyte. It will initially assess safety and tolerability before moving into an efficacy expansion cohort. See our latest analysis for Incyte. The...

Noble Corporation plc has already reported its first-quarter 2026 results on April 26, 2026, followed by a conference call on April 27, with materials made available on its website. At the same time, Noble and peer Seadrill have drawn attention as beneficiaries of rising energy prices and tighter offshore drilling supply, reinforcing the perception that leading offshore contractors are well placed in a consolidating sector. We’ll now consider how Noble’s positioning as a beneficiary of...

Globant (GLOB) has been named an Autodesk Tandem Digital Twin Solution Provider, expanding a 15 year collaboration to support digital twin deployments across airports, smart buildings, manufacturing facilities and logistics environments worldwide. See our latest analysis for Globant. The recent client wins in digital twins and AI based compliance come against a backdrop of a 31.9% decline in the 90 day share price return and a 57.3% fall in the 1 year total shareholder return, suggesting...

Tesla received regulatory approval for its Full Self-Driving supervised technology in the Netherlands after extensive testing. Dutch authorities have started the process for EU wide approval by formally notifying the European Commission. This is the first step that could allow Tesla's supervised autonomous driving system to be legally offered across the European Union. Tesla (NasdaqGS:TSLA) is drawing fresh attention as regulators in the Netherlands back its Full Self-Driving supervised...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Costamare...

Before getting into the numbers, it helps to ask a simple question: at around US$31.65 per share, are you paying a fair price for Kinder Morgan or leaving value on the table? Recent returns have been mixed, with the share price down around 5.0% over the last week and 5.2% over the last month, while still showing a 14.2% gain year to date and 21.3% over the past year. Short-term moves like these often sit against a longer backdrop. In Kinder Morgan's case, the 3 year return is 109.7% and the 5...

Take-Two Interactive Software (NasdaqGS:TTWO) is preparing a new iteration of GTA Online alongside the future launch of Grand Theft Auto VI. The refreshed GTA Online is expected to continue using in-game purchases that have supported recurring, high-margin revenue for the company over the past decade. Investors are watching how this updated online platform could influence the mix and stability of Take-Two's digital revenue profile. For anyone following NasdaqGS:TTWO, the focus now is less...

Match Group stock snapshot after recent gains Match Group (MTCH) has drawn fresh attention after a recent stretch of gains, with the stock up about 9.1% over the past month and 5% over the past 3 months. See our latest analysis for Match Group. The recent 9.1% 30 day share price return and 5.8% year to date share price return sit against a mixed longer record, with an 18.3% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns. This suggests momentum has picked up...

If you are wondering whether InterDigital's share price still reflects its underlying value after a strong run, this breakdown is aimed at helping you frame that question clearly. The stock recently closed at US$352.32, with returns of 11.7% over 7 days, 8.0% year to date and 75.2% over 1 year, while the 3 year and 5 year returns are both very large. Recent headlines around InterDigital have focused on its role in software and licensing, along with ongoing interest in how its technology...

Albertsons Companies (ACI) has put another quarter on the board, with Q3 FY 2026 revenue of US$19.1b, basic EPS of US$0.55 and net income of US$293.3m, plus same store sales growth of 2.4%. Over the past few quarters, the company has reported revenue of US$18.8b in Q2 FY 2026 and US$18.8b in Q3 FY 2025, rising to US$19.1b in the latest quarter. Basic EPS over the same periods was US$0.30 and US$0.69 respectively, before reaching US$0.55 in Q3 FY 2026. These figures set the scene for investors...

Investors may be wondering whether Old Republic International at around US$41.37 still offers value, or if most of the opportunity has already been priced in. The stock has returned 2.2% over the last 7 days and 3.2% over the past month. The year-to-date return is a 4.4% decline, while the 1-year return is 19.4%, with 3-year and 5-year returns of 101.0% and 157.6% respectively. This provides a mixed picture across different time frames. Recent coverage has focused on Old Republic...

Innovative Industrial Properties (NYSE:IIPR) disclosed that long-serving director Gary Kreitzer will retire from the board and not stand for re election at the 2026 annual meeting. The company stated that Kreitzer’s decision is not tied to any disagreement with management or the board. Kreitzer has served since the board’s inception and has been closely involved as the business expanded within the specialized industrial real estate segment. The announcement highlights an upcoming transition...

Riley Exploration Permian, Inc. recently presented at the Water Tower Research Insights Conference on April 14, 2026, offering investors and analysts fresh commentary on its operations and outlook. This conference appearance gives the company a platform to explain its infrastructure plans in New Mexico and ERCOT power initiatives directly to the market. We’ll now consider how this conference presentation, and any additional detail on New Mexico infrastructure and ERCOT power projects, might...

Cambiar Investors LLC acquired over 53,000 shares of CF Industries Holdings in late 2025, while the company reported solid full-year earnings and returned US$1.34 billion to shareholders via buybacks that trimmed its share count by nearly 10%. At the same time, insider selling, concerns that the share price sits well above certain intrinsic value estimates, and a consensus “Hold” rating highlight tensions between strong operations and skepticism about how much is already priced in. Next,...

The Schall Law Firm has opened a securities law investigation into Simply Good Foods (NasdaqCM:SMPL). The probe centers on whether the company misled investors or omitted material information before cutting guidance and recording an impairment. This follows earlier attention on the company’s weak earnings, impaired outlook, and share price decline. Simply Good Foods, known for its branded nutritional snacks and meal replacement products, now faces legal scrutiny in addition to its recent...

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying small-cap stocks that are potentially undervalued and exhibit insider buying can offer intriguing opportunities for investors seeking to capitalize on current market conditions.

Over the last week, the United States market has seen a 4.4% increase, contributing to an impressive 32% rise over the past year, with earnings expected to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer investors opportunities for growth by focusing on companies with strong fundamentals and attractive valuations relative to their peers.

The United States market has experienced a notable upswing, climbing 4.4% in the last week and showing a robust 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and potential alignment with shareholder interests.

The market has climbed 4.4% in the last 7 days and is up 32% over the past year, with earnings forecasted to grow by 16% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer significant opportunities when they have solid financials. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, giving investors a chance to uncover hidden value in quality companies.

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying stocks that combine solid fundamentals with growth potential can uncover promising opportunities for investors seeking undiscovered gems.

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this robust market environment, dividend stocks with yields of at least 3% can offer investors a combination of income and potential capital appreciation, making them an attractive option for those seeking steady returns amidst growth opportunities.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Earlier this month, BioCryst Pharmaceuticals, Inc. appointed Sandeep M. Menon, MD, PhD, a veteran of Alnylam and Pfizer, as Chief Research and Development Officer, bringing extensive experience in global clinical development, biostatistics and rare disease drug approvals. His background in advancing complex therapies like RNAi drugs and leading AI-enabled R&D organizations may meaningfully influence how BioCryst prioritizes and executes its future development pipeline. Next, we’ll explore...